News / Taiwan / economic_daily
Shi-Ji Biotech to List on Emerging Stock Market on Nov 23
Health Technology · Biotechnology · economic_daily · 2026-11-18
6623
Shi-Ji Biotech is set to debut on the emerging stock market at NT$80 per share, focusing on plasma medical equipment and AI-driven healthcare solutions.
What Happened
Listing Details: Shi-Ji Biotech is scheduled to list on the emerging stock market on November 23 with a reference price of NT$80 per share, with management identifying 2027 as a pivotal year for growth.
Dual-Engine Strategy: The company operates on a dual-engine strategy of plasma medical technology and AI-driven healthcare, focusing on equipment sales in the short term and recurring revenue from AI model subscriptions in the long term.
Financial Goals: As plasma medical equipment is increasingly adopted by domestic medical centers, the company expects to potentially turn profitable next year, contingent on the approval of self-pay medical fees.
Strategic Partnership: Shi-Ji Biotech has partnered with APMIC to develop a sovereign AI medical brain, aiming to establish a second growth engine and strengthen its position in the innovative medical device sector.